May 17th
May 8th
April 5th
February 22nd
February 18th
February 17th
February 16th
February 13th
February 5th
January 19th
November 2nd
October 20th
July 22nd
No video for Neutrophil is available at this time.
CytRx (CYTR) Reports Favorable Progress Update for Ongoing Phase 2 ... - StreetInsider.com
CytRx Corporation (NASDAQ: CYTR ) today provided a favorable progress update for its ongoing Phase 2 STAR-1 registration clinical trial to evaluate the efficacy and safety of orally administered tamibarotene as a third-line treatment for acute ...
NURSE?S NOTES - Rare but serious blood disorder - Missoulian
Neutropenia is a blood disorder that occurs when someone has an abnormally low number of white blood cells called neutrophils. The body protects itself against the constant risk of infection by making a lot of neutrophils. They attack and destroy ...
CytRx Reports Progress Update for Its Pivotal Phase 2 Clinical Trial - TradingMarkets.com
The primary endpoint of the open-label, non-randomized STAR-1 trial is to determine the rate of durable complete response for tamibarotene therapy when administered as a single agent to adult patients following treatment failure with all-trans ...
StandoutStocks.com: "Stocks that Standout" picks for today are: CYTR ... - TradingMarkets.com
Jun 29, 2009 -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today provided a favorable progress update for its ongoing Phase 2 STAR-1 registration ...
Do you prefer to listen to your neutrophil gossip? Check out Podzy Podcast Directory > Neutrophil.
Looking for neutrophil related products, then look no further. Try our new Neutrophil Shop.